ReviewBlood advances2021
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
Christina-Nefeli Kontandreopoulou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled itcites it